Area of research
Genetics · Epidemiology
Research interest
Research interests include Inflammatory Bowel Disease, Microscopic Colitis, Biosimilars and Bioanalytical Methods, and Rheumatoid Arthritis Research and Therapies.
Janus Kinase Inhibitor-Induced Acne in Inflammatory Bowel Disease: An International, Multicenter, Retrospective Cohort Study
Overcoming the challenges of overtreating and undertreating inflammatory bowel disease
Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential
Comparative Effectiveness of Tofacitinib vs Upadacitinib for the Treatment of Acute Severe Ulcerative Colitis
Sphingosine-1-Phosphate (S1P) Receptor Modulators for the Treatment of Inflammatory Bowel Disease (IBD): Mechanisms, Clinical Evidence, and Practical Insights
Anti-tumor Necrosis Factor Drug Concentration Is Not Associated with Disease Outcomes in Pouchitis: A Retrospective, International Study
Epidemiology of Inflammatory Bowel Disease across the Ages in the Era of Advanced Therapies
Navigating the complexities of drug development for inflammatory bowel disease
Biomarkers in inflammatory bowel disease: a practical guide
Acute severe ulcerative colitis trials: the past, the present and the future
Basket, Umbrella, and Platform Trials: The Potential for Master Protocol–Based Trials in Inflammatory Bowel Disease
JAK inhibitors for inflammatory bowel disease: recent advances
An update on the safety of long-term vedolizumab use in inflammatory bowel disease
A retrospective cohort study: pre‐operative oral enteral nutritional optimisation for Crohnʼs disease in a <scp>UK</scp> tertiary <scp>IBD</scp> centre
Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience
Tofacitinib in Acute Severe Ulcerative Colitis—A Real-World Tertiary Center Experience